Silver Book

Silver Book Fact

Mitral regurgitation patients who did not undergo surgery saw an increased use of medical therapies from 12% to 47% over 4.5 years.

Prevalence and Outcomes of Unoperated Patients with Severe Symptomatic Mitral Regurgitation and Heart Failure. J Am Coll Cardiol. 2014; 63(2). http://www.onlinejacc.org/content/63/2/185

Reference

Title
Prevalence and Outcomes of Unoperated Patients with Severe Symptomatic Mitral Regurgitation and Heart Failure
Publication
J Am Coll Cardiol
Publication Date
2014
Volume & Issue
Volume 63, Issue 2
URL
Read Full Resource

Categories

  • Cost of Disease
  • Human Burden

Publications

Silver Book: Valve Disease Volume

 https://www.silverbook.org/wp-content/uploads/2018/02/SB-Vol-TN.jpg Thumbnail

Connected Facts

Aortic Stenosis

Fact image
Aortic stenosis often undertreated
Cost of Disease

Mitral Valve Disease

Fact image
Human Burden

Mitral Valve Disease

Fact image
Patients with severe MR who don’t have surgery have mortality rates of 20% after 1-year and 50% after 5-years
Human Burden

Aortic Stenosis

Fact image
Medicare patients with sSAS have an average lifespan of 1.8 years without repair or replacement
Human Burden

Related Facts

  • Atrial fibrillation prevalence by age, 2001
    Atrial fibrillation affects around 1 in 25 Americans age 60 and older, increasing to close to 1 in 10 adults by age 80.  
  • The median survival time after a first stroke are: at 60-69 years of age–6.8 years for men and 7.4 years for women; at 70-79 years of age–5.4 years for men…  
  • Atrial fibrillation prevalence projection, 2050
    Atrial fibrillation prevalence is projected to rise to between 5.6 and 12.1 million in 2050.  
  •  
  • Undertreatment of patients with sSAS
    AS is often undertreated — one study found that 56% of severe symptomatic aortic stenosis (sSAS) patients referred to a cardiothoracic surgeon were not operated on.